Leidos director awarded dividend-equivalent shares

Q: Does the Leidos (LDOS) Form 4 show any insider share sales?

The Form 4 does not show any insider share sales. It reports one acquisition of 6.9569 dividend-equivalent shares under a Key Executive Stock Deferral Plan and two lines updating direct and indirect holdings without indicating open-market buying or selling.

Leidos Holdings, Inc. director Robert S. Shapard reported a small compensation-related share award rather than an open-market trade.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Leidos Holdings, Inc. director Robert S. Shapard reported a small compensation-related share award rather than an open-market trade. On June 30, 2026, he acquired 6.9569 shares of common stock at $0.0000 per share as dividend equivalent rights credited under a Key Executive Stock Deferral Plan, increasing that indirect plan holding to 1,631.9523 shares. He also reports 2,500 shares held indirectly through a family limited partnership and 60,027.0800 shares held directly.

Insider Trade Summary

Grant/Award: 6.9569 shares

Grant/Award 3 txns

Insider SHAPARD ROBERT S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6.9569	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,631.9523 shares (Indirect, by Key Executive Stock Deferral Plan); Common Stock — 60,027.08 shares (Direct); Common Stock — 2,500 shares (Indirect, By Family Limited Partnership)

Footnotes (1)

F1. Dividend equivalent rights.

Key Figures

Dividend-equivalent shares awarded: 6.9569 shares Deferred plan holdings after award: 1,631.9523 shares Family limited partnership holdings: 2,500 shares +1 more

4 metrics

Dividend-equivalent shares awarded 6.9569 shares Common Stock grant on June 30, 2026 at $0.0000 per share

Deferred plan holdings after award 1,631.9523 shares Indirect holdings by Key Executive Stock Deferral Plan after dividend equivalents

Family limited partnership holdings 2,500 shares Indirect holdings by Family Limited Partnership

Directly held shares 60,027.0800 shares Direct ownership of Leidos common stock

Key Terms

Dividend equivalent rights, Key Executive Stock Deferral Plan, Family Limited Partnership

3 terms

Dividend equivalent rights financial

"Dividend equivalent rights."

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

Key Executive Stock Deferral Plan financial

"nature_of_ownership": "by Key Executive Stock Deferral Plan""

Family Limited Partnership financial

"nature_of_ownership": "By Family Limited Partnership""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Leidos (LDOS) director Robert S. Shapard report?

Leidos director Robert S. Shapard reported a small, compensation-related acquisition of common stock. He received 6.9569 dividend-equivalent shares under a Key Executive Stock Deferral Plan, rather than making any open-market purchase or sale, and updated his reported holdings.

How many Leidos (LDOS) shares did Robert S. Shapard receive in this Form 4?

Robert S. Shapard received 6.9569 shares of Leidos common stock. These shares were credited as dividend equivalent rights in a Key Executive Stock Deferral Plan at a stated price of $0.0000 per share, reflecting a non-cash, compensation-related award.

What are Robert S. Shapard’s reported Leidos (LDOS) holdings after this transaction?

After this transaction, Robert S. Shapard reports 1,631.9523 shares held indirectly via a Key Executive Stock Deferral Plan, 2,500 shares held indirectly through a family limited partnership, and 60,027.0800 shares held directly in Leidos common stock.

What does “dividend equivalent rights” mean in the Leidos (LDOS) Form 4 filing?

In this context, dividend equivalent rights are additional stock credits tied to existing deferred holdings. Shapard received 6.9569 Leidos common shares as dividend equivalents into a Key Executive Stock Deferral Plan, increasing his indirect deferred share balance without a cash transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/02/2026 - 04:24 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHAPARD ROBERT S

(Last)

(First)

(Middle)

1750 PRESIDENTS STREET

(Street)

RESTON

VIRGINIA

20190

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/30/2026		A		6.9569⁽¹⁾	A	$0	1,631.9523	I	by Key Executive Stock Deferral Plan
Common Stock								60,027.08	D
Common Stock								2,500	I	By Family Limited Partnership

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Dividend equivalent rights.

Remarks:

	/s/ Ramune M. Kligys by PoA of Robert S. Shapard	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR